Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium

Reinhard Haessler, Richard F. Davis, Roger A. Wolff, Koh Kuzume, Robert Shangraw, Donna M. Van Winkle

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Dichloroacetate (DCA), an activator of pyruvate dehydrogenase (PDHC), enhances postischemic mechanical recovery of isolated hearts. It is not known whether this is secondary to reduced infarction or preservation of contractile function in viable cardiomyocytes. This study investigated the effect of DCA on myocardial infarct size. Anesthetized open chest rabbits underwent regional coronary occlusion and reperfusion. DCA (300 mg/kg plus 150 mg/kg 1 h later) was administered intravenously either before occlusion (DCA-O; n = 8) or at reperfusion (DCA-R; n = 7). Control rabbits (n = 8) received saline vehicle. Myocardial PDHC activity was measured after administration of 300 mg/kg i.v. DCA in 10 separate rabbits. DCA reduced plasma lactate levels and increased PDHC activity by 76%, from 2.79 ± .30 μmol/minK·g-1 to 4.92 ± .44 μmol/min·g-1 (p <.005). However, infarct size in DCA-treated animals was not significantly different from Control (60 ± 5% DCA-O, 57 ± 6% DCA-R, 58 ± 7% Control). We conclude that stimulation of pyruvate dehydrogenase does not limit infarct size.

Original languageEnglish (US)
Pages (from-to)66-71
Number of pages6
JournalShock
Volume5
Issue number1
StatePublished - 1996

Fingerprint

Lactic Acid
Myocardium
Rabbits
Myocardial Reperfusion
Coronary Occlusion
Pyruvic Acid
Cardiac Myocytes
Infarction
Reperfusion
Oxidoreductases
Thorax
Myocardial Infarction
pyruvate dehydrogenase activator

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Physiology

Cite this

Haessler, R., Davis, R. F., Wolff, R. A., Kuzume, K., Shangraw, R., & Van Winkle, D. M. (1996). Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium. Shock, 5(1), 66-71.

Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium. / Haessler, Reinhard; Davis, Richard F.; Wolff, Roger A.; Kuzume, Koh; Shangraw, Robert; Van Winkle, Donna M.

In: Shock, Vol. 5, No. 1, 1996, p. 66-71.

Research output: Contribution to journalArticle

Haessler, R, Davis, RF, Wolff, RA, Kuzume, K, Shangraw, R & Van Winkle, DM 1996, 'Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium', Shock, vol. 5, no. 1, pp. 66-71.
Haessler, Reinhard ; Davis, Richard F. ; Wolff, Roger A. ; Kuzume, Koh ; Shangraw, Robert ; Van Winkle, Donna M. / Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium. In: Shock. 1996 ; Vol. 5, No. 1. pp. 66-71.
@article{8d372e120054483abe5b34fd1dfd6192,
title = "Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium",
abstract = "Dichloroacetate (DCA), an activator of pyruvate dehydrogenase (PDHC), enhances postischemic mechanical recovery of isolated hearts. It is not known whether this is secondary to reduced infarction or preservation of contractile function in viable cardiomyocytes. This study investigated the effect of DCA on myocardial infarct size. Anesthetized open chest rabbits underwent regional coronary occlusion and reperfusion. DCA (300 mg/kg plus 150 mg/kg 1 h later) was administered intravenously either before occlusion (DCA-O; n = 8) or at reperfusion (DCA-R; n = 7). Control rabbits (n = 8) received saline vehicle. Myocardial PDHC activity was measured after administration of 300 mg/kg i.v. DCA in 10 separate rabbits. DCA reduced plasma lactate levels and increased PDHC activity by 76{\%}, from 2.79 ± .30 μmol/minK·g-1 to 4.92 ± .44 μmol/min·g-1 (p <.005). However, infarct size in DCA-treated animals was not significantly different from Control (60 ± 5{\%} DCA-O, 57 ± 6{\%} DCA-R, 58 ± 7{\%} Control). We conclude that stimulation of pyruvate dehydrogenase does not limit infarct size.",
author = "Reinhard Haessler and Davis, {Richard F.} and Wolff, {Roger A.} and Koh Kuzume and Robert Shangraw and {Van Winkle}, {Donna M.}",
year = "1996",
language = "English (US)",
volume = "5",
pages = "66--71",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Dichloroacetate reduces plasma lactate levels but does not reduce infarct size in rabbit myocardium

AU - Haessler, Reinhard

AU - Davis, Richard F.

AU - Wolff, Roger A.

AU - Kuzume, Koh

AU - Shangraw, Robert

AU - Van Winkle, Donna M.

PY - 1996

Y1 - 1996

N2 - Dichloroacetate (DCA), an activator of pyruvate dehydrogenase (PDHC), enhances postischemic mechanical recovery of isolated hearts. It is not known whether this is secondary to reduced infarction or preservation of contractile function in viable cardiomyocytes. This study investigated the effect of DCA on myocardial infarct size. Anesthetized open chest rabbits underwent regional coronary occlusion and reperfusion. DCA (300 mg/kg plus 150 mg/kg 1 h later) was administered intravenously either before occlusion (DCA-O; n = 8) or at reperfusion (DCA-R; n = 7). Control rabbits (n = 8) received saline vehicle. Myocardial PDHC activity was measured after administration of 300 mg/kg i.v. DCA in 10 separate rabbits. DCA reduced plasma lactate levels and increased PDHC activity by 76%, from 2.79 ± .30 μmol/minK·g-1 to 4.92 ± .44 μmol/min·g-1 (p <.005). However, infarct size in DCA-treated animals was not significantly different from Control (60 ± 5% DCA-O, 57 ± 6% DCA-R, 58 ± 7% Control). We conclude that stimulation of pyruvate dehydrogenase does not limit infarct size.

AB - Dichloroacetate (DCA), an activator of pyruvate dehydrogenase (PDHC), enhances postischemic mechanical recovery of isolated hearts. It is not known whether this is secondary to reduced infarction or preservation of contractile function in viable cardiomyocytes. This study investigated the effect of DCA on myocardial infarct size. Anesthetized open chest rabbits underwent regional coronary occlusion and reperfusion. DCA (300 mg/kg plus 150 mg/kg 1 h later) was administered intravenously either before occlusion (DCA-O; n = 8) or at reperfusion (DCA-R; n = 7). Control rabbits (n = 8) received saline vehicle. Myocardial PDHC activity was measured after administration of 300 mg/kg i.v. DCA in 10 separate rabbits. DCA reduced plasma lactate levels and increased PDHC activity by 76%, from 2.79 ± .30 μmol/minK·g-1 to 4.92 ± .44 μmol/min·g-1 (p <.005). However, infarct size in DCA-treated animals was not significantly different from Control (60 ± 5% DCA-O, 57 ± 6% DCA-R, 58 ± 7% Control). We conclude that stimulation of pyruvate dehydrogenase does not limit infarct size.

UR - http://www.scopus.com/inward/record.url?scp=0029684002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029684002&partnerID=8YFLogxK

M3 - Article

C2 - 8821106

AN - SCOPUS:0029684002

VL - 5

SP - 66

EP - 71

JO - Shock

JF - Shock

SN - 1073-2322

IS - 1

ER -